China Medical News

"Top 20 sales enterprises should take more than 80% of the market share on the national essential drug list." This was formally written and signed by three government departments*. If this statement was actually implemented, "Designated Production" would lead essential drug industries to a large-scale intensive development.
Additionally, it is also stated that "Sales Revenue of Top 100 pharmaceutical companies should account for more than 50% (currently 40%) share of the entire industry in the next 5 years." There will be more M&A opportunities in the industry because of the 10% increase helped by the government.

*3 departments: Ministry of Industry and Information Technology, Ministry of Health, State Food and Drug Administration.

It has been reported that the SFDA(State Food and Drug Administration) will revise the "Medicine Advertisement Examination Rule" on Sep. 25th to restrict or ban OTC drug advertising in the mass media. On Sep. 27th, the chairman of China's OTC drug association, Mr. Bai HuiLiang, confirmed that: on Sep.28th, the SFDA and other departments will organize a professional meeting to discuss this issue; whether OTC advertising will be limited or not is still under discussion.
According to China's OTC drug association, the market size of OTC medicine in 2011 increased to approximately 140 billion RMB, at least 5% of which was turned to advertising expenses.
If OTC advertisement is forbidden, it is expected that both the pharmaceutical and advertisement industries will receive a blow.